References
- Mallet L. Caring for the elderly patient. J Am Pharm Assoc 1996;43:628–35
- Fu Y, Yang S, Jeong SH, et al. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst 2004;21:433–76
- Montgomery W, Treuer T, Karagianis J, et al. Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties. Patient Prefer Adherence 2012;6:109–25
- Brown D. Orally disintegrating tablets: taste over speed. Drug Dev Technol 2001;3:58–61
- Maniruzzaman M, Boateng JS, Bonnefille M, et al. Taste masking of paracetamol by hot-melt extrusion: an in vitro and in vivo evaluation. Eur J Pharm Biopharm 2012;80:433–42
- Douroumis D. Practical approaches of taste masking technologies in oral solid forms. Expert Opin Drug Deliv 2007;4:417–26
- Kasturagi Y, Kurihara K. Specific in-vitro bitter taste. Nature 1993;365:213–14
- Ayenew Z, Puri V, Kumar L, Bansal AK. Trends in pharmaceutical taste masking technologies: a patent review. Recent Pat Drug Deliv Formul 2009;3:26–39
- Arima H, Higashi T, Motoyama K. Improvement of the bitter taste of drugs by complexation with cyclodextrins: applications, evaluations and mechanisms. Ther Deliv 2012;3:633–44
- Shah PP, Mashru RC, Rane YM, Thakkar A. Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking. AAPS PharmSciTech 2008;9:377–89
- Damini NC, Tsau JH. Taste-masking compositions. Patent no. EP0212641; 1987
- Hussain MA, Aungst BJ, Koval CA, Shefter E. Improved buccal delivery of opioid analgesics and antagonists with bitterless prodrugs. Pharm Res 1988;5:615–18
- Suhagiya VK, Goyani AN, Gupta RN. Taste masking by ion exchange resin and its new applications: a review. Int J Pharm Sci Res 2010;1:22–36
- Siegel S, Reiner RH, Zelinskie JA, Hanus EJ. Tablets of pyrilamine resin adsorbate with aspirin and vitamin C. J Pharm Sci 1962;51:1068–71
- Sakr AM, Aboutaleb AE, Elsabagh HM, Aly AM. Comparative effectiveness of certain disintegrants of directly compressed sulfadimidine tablets. Egypt J Pharm Sci 1979;18:219–33
- Chen T, Burton MA, Codde JP, et al. Evaluation of ion-exchange microspheres as carriers for the anticancer drug doxorubicin: in-vitro studies. J Pharm Pharmacol 1991;44:211–15
- Lu MF, Borodkin S, Woodward L, et al. A polymer carrier system for taste masking of macrolide antibiotics. Pharm Res 1991;8:184–8
- Agarwal R, Mittal R, Singh A. Studies of ion-exchange resin complex of chloroquine phosphate. Drug Dev Ind Pharm 2000;26:773–6
- Kaushik D, Dureja H, Saini TR. Mouth dissolving tablets: a review. Indian Drugs 2004;41:187–93
- Wang LY, Wang Y, Zheng JQ, et al. Pharmacological profiles of an anticholinergic agent, phencynonate hydrochloride, and its optical isomers. Acta Pharmacol Sin 2005;26:527–32
- Borodkin S, Sundberg DP. Polycarboxylic acid ion-exchange resin adsorbates for taste coverage in chewable tablets. J Pharm Sci 1971;60:1523–7
- Zhang ZY, Ping QN, Xiao B. Microencapsulation and characterization of tramadol-resin complexes. J Control Release 2000;66:107–13
- Adair SM, Whitford GM, McKnight-Hanes C. Effect of artificial saliva and calcium on fluoride output of controlled-release devices. Caries Res 1994;28:28–34
- Kim JI, Cho SM, Cui JH, et al. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex. Int J Pharm 2013;455:31–9
- Abdelbary G, Eouani C, Prinderre P, et al. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm 2005;292:29–41
- Jeong SH, Park K. Drug loading and release properties of ion-exchange resin complexes as a drug delivery matrix. Int J Pharm 2008;361:26–32
- Ribeiro MHL, Ribeiro IAC. Recovery of erythromycin from fermentation broth by adsorption onto neutral and ion-exchange resins. Sep Purif Technol 2005;45:232–9
- Tawakkul MA, Shah RB, Zidan A, et al. Complexation of risperidone with a taste-masking resin: novel application of near infra-red and chemical imaging to evaluate complexes. Pharm Dev Technol 2009;14:409–21
- McCormick D. Evolution in direct compression. Pharm Technol 2005;4:52–62
- Aurora J, Pathak V. Oral disintegrating technologies: oral disintegrating dosage forms: an overview. Drug Deliv Technol 2005;5:50–4
- Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets. AAPS PharmSciTech 2007;8:E1–7
- Sheshaka R, Khan N, Chitneni M, Darwis Y. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants. Arch Pharm Res 2011;34:1945–56
- Kuno Y, Kojima M, Ando S, Nakagami H. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols. J Control Release 2005;105:6–22
- Dobetti L. Fast-melting tablets: developments and technologies. Pharm Technol 2001;25:44–50
- Borodkin S, Yunker MH. Interaction of amine drugs with a polycarboxylic acid ion-exchange resin. J Pharm Sci 1970;59:481–6
- Puttewar TY, Kshirsagar MD, Chandewar AV, Chikhale RV. Formulation and evaluation of orodispersible tablet of taste masked doxylamine succinate using ion exchange resin. J King Saud Univ 2010;22:229–40